发明名称 GLP-1 Exendin-4 peptide analogs and uses thereof
摘要 <p>The invention relates to novel polypeptide analogues of GLP- I and exendin-4. The polypeptide, in a preferred embodiment, is insulinotropic and long-acting. 5 Preferably, the polypeptide's insulinotropic effect is comparable to or exceeds the effect of an equimolar amount of GLP- 1 or exendin-4. The invention also relates to a method of treating a subject with diabetes, comprising administering to the subject the polypeptide of the invention in an amount that has an insulinotropic effect. The invention also relates to methods of using GLP-1, exendin-4, and polypeptide analogues 10 thereof for neuroprotective and neurotrophic effects.</p>
申请公布号 AU2008202893(B2) 申请公布日期 2012.01.12
申请号 AU20080202893 申请日期 2008.07.01
申请人 THE GOVERNMENT OF THE UNITED STATES OF AMERICA ASREPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 发明人 GREIG, NIGEL H;PERRY, TRACY ANN;DOYLE, MAIRE;HOLLOWAY, HAROLD;EGAN, JOSEPHINE
分类号 A61K38/28;C07K14/47;A61K38/00;A61K38/26;A61P3/10;A61P9/10;A61P19/08;A61P25/00;A61P25/02;A61P25/14;A61P25/16;A61P25/28;A61P43/00;C07K14/575;C07K14/605 主分类号 A61K38/28
代理机构 代理人
主权项
地址